Author

Iago Rodríguez-Lago

LONG-TERM OUTCOMES OF BIOLOGIC THERAPY IN CROHN’S DISEASE COMPLICATED WITH INTERNAL FISTULIZING DISEASE: BIOSCOPE STUDY FROM GETECCU
LONG-TERM OUTCOMES OF BIOLOGIC THERAPY IN CROHN’S DISEASE COMPLICATED WITH INTERNAL FISTULIZING DISEASE: BIOSCOPE STUDY FROM GETECCU

Iago Rodríguez-Lago

Introduction to the first paper on: IBD
Introduction to the first paper on: IBD

Iago Rodríguez-Lago

SUBCLINICAL INFLAMMATORY BOWEL DISEASE PRECEDES THE DIAGNOSIS AND LEADS TO AN INCREASE IN HEALTHCARE RESOURCES UTILIZATION: MULTICENTER CASE-CONTROL STUDY
SUBCLINICAL INFLAMMATORY BOWEL DISEASE PRECEDES THE DIAGNOSIS AND LEADS TO AN INCREASE IN HEALTHCARE RESOURCES UTILIZATION: MULTICENTER CASE-CONTROL STUDY

SEROLOGIC RESPONSE WITH ANTIMICROBIAL ANTIBODIES DURING THE PRECLINICAL PHASE OF INFLAMMATORY BOWEL DISEASE
SEROLOGIC RESPONSE WITH ANTIMICROBIAL ANTIBODIES DURING THE PRECLINICAL PHASE OF INFLAMMATORY BOWEL DISEASE

LONG-TERM OUTCOMES OF BIOLOGIC THERAPY IN CROHN’S DISEASE COMPLICATED WITH INTERNAL FISTULIZING DISEASE: BIOSCOPE STUDY FROM GETECCU
LONG-TERM OUTCOMES OF BIOLOGIC THERAPY IN CROHN’S DISEASE COMPLICATED WITH INTERNAL FISTULIZING DISEASE: BIOSCOPE STUDY FROM GETECCU

Iago Rodríguez-Lago  et al.

LONG-TERM OUTCOMES OF ENTEROCUTANEOUS FISTULA COMPLICATING CROHN'S DISEASE: ECUFIT STUDY FROM GETECCU
LONG-TERM OUTCOMES OF ENTEROCUTANEOUS FISTULA COMPLICATING CROHN'S DISEASE: ECUFIT STUDY FROM GETECCU

LONG-TERM OUTCOMES OF BIOLOGIC THERAPY IN CROHN'S DISEASE COMPLICATED WITH INTERNAL FISTULIZING DISEASE: BIOSCOPE STUDY FROM GETECCU
LONG-TERM OUTCOMES OF BIOLOGIC THERAPY IN CROHN'S DISEASE COMPLICATED WITH INTERNAL FISTULIZING DISEASE: BIOSCOPE STUDY FROM GETECCU

UEG Week+ | Burnout in European Gastroenterology - A call to action
UEG Week+ | Burnout in European Gastroenterology - A call to action

Iago Rodríguez-Lago  et al.

COMBINATION OF GRANULOCYTE–MONOCYTE APHERESIS AND TOFACITINIB: MULTICENTRE AND RETROSPECTIVE STUDY
COMBINATION OF GRANULOCYTE–MONOCYTE APHERESIS AND TOFACITINIB: MULTICENTRE AND RETROSPECTIVE STUDY

Iago Rodríguez-Lago  et al.

LONG-TERM OUTCOMES OF ENTEROCUTANEOUS FISTULA COMPLICATING CROHN’S DISEASE: ECUFIT STUDY FROM GETECCU
LONG-TERM OUTCOMES OF ENTEROCUTANEOUS FISTULA COMPLICATING CROHN’S DISEASE: ECUFIT STUDY FROM GETECCU

Iago Rodríguez-Lago  et al.

SEROLOGIC RESPONSE WITH ANTIMICROBIAL ANTIBODIES DURING THE PRECLINICAL PHASE OF INFLAMMATORY BOWEL DISEASE
SEROLOGIC RESPONSE WITH ANTIMICROBIAL ANTIBODIES DURING THE PRECLINICAL PHASE OF INFLAMMATORY BOWEL DISEASE

Iago Rodríguez-Lago  et al.

SUBCLINICAL INFLAMMATORY BOWEL DISEASE PRECEDES THE DIAGNOSIS AND LEADS TO AN INCREASE IN HEALTHCARE RESOURCES UTILIZATION: MULTICENTER CASE-CONTROL STUDY
SUBCLINICAL INFLAMMATORY BOWEL DISEASE PRECEDES THE DIAGNOSIS AND LEADS TO AN INCREASE IN HEALTHCARE RESOURCES UTILIZATION: MULTICENTER CASE-CONTROL STUDY

Iago Rodríguez-Lago  et al.

CHARACTERISTICS AND MANAGEMENT OF PYODERMA GANGRENOSUM AND ERYTHEMA NODOSUM IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: PIONOSO MULTICENTER STUDY
CHARACTERISTICS AND MANAGEMENT OF PYODERMA GANGRENOSUM AND ERYTHEMA NODOSUM IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: PIONOSO MULTICENTER STUDY

Iago Rodríguez-Lago  et al.

TRANSMURAL CROSS-SECTIONAL FINDINGS AND BOWEL DAMAGE ASSESSMENT IN PRECLINICAL CROHN’S DISEASE: A CASE-CONTROL STUDY
TRANSMURAL CROSS-SECTIONAL FINDINGS AND BOWEL DAMAGE ASSESSMENT IN PRECLINICAL CROHN’S DISEASE: A CASE-CONTROL STUDY

Iago Rodríguez-Lago  et al.

PREVALENCE OF UNDIAGNOSED INFLAMMATORY BOWEL DISEASE IN PATIENTS WITH SPONDYLOARTHRITIS: EISER STUDY
PREVALENCE OF UNDIAGNOSED INFLAMMATORY BOWEL DISEASE IN PATIENTS WITH SPONDYLOARTHRITIS: EISER STUDY

Iago Rodríguez-Lago  et al.

INFLAMMATORY BOWEL DISEASE (IBD) AND IMMUNOSUPPRESSION DO NOT WORSEN THE PROGNOSIS OF COVID-19. RESULTS FROM THE ENEIDA PROJECT OF GETECCU
INFLAMMATORY BOWEL DISEASE (IBD) AND IMMUNOSUPPRESSION DO NOT WORSEN THE PROGNOSIS OF COVID-19. RESULTS FROM THE ENEIDA PROJECT OF GETECCU

Iago Rodríguez-Lago  et al.

COMORBIDITIES AND EPIDEMIOLOGICAL RISK FACTOR BUT NOT IMMUNOSUPPRESSIVE THERAPIES INCREASE THE RISK OF COVID-19 IN INFLAMMATORY BOWEL DISEASE (IBD): AN ENEIDA-BASED, CASE-CONTROL STUDY
COMORBIDITIES AND EPIDEMIOLOGICAL RISK FACTOR BUT NOT IMMUNOSUPPRESSIVE THERAPIES INCREASE THE RISK OF COVID-19 IN INFLAMMATORY BOWEL DISEASE (IBD): AN ENEIDA-BASED, CASE-CONTROL STUDY

Iago Rodríguez-Lago  et al.

NEW INSIGHTS INTO THE MECHANISM OF ACTION OF GRANULOCYTE-MONOCYTE APHERESIS REVEALED BY SINGLE-CELL TRANSCRIPTOMIC ANALYSIS
NEW INSIGHTS INTO THE MECHANISM OF ACTION OF GRANULOCYTE-MONOCYTE APHERESIS REVEALED BY SINGLE-CELL TRANSCRIPTOMIC ANALYSIS

Iago Rodríguez-Lago  et al.

VACCINATION STRATEGIES IN INFLAMMATORY BOWEL DISEASE PATIENTS: PERSPECTIVE OF PHYSICIANS AND PATIENTS.
VACCINATION STRATEGIES IN INFLAMMATORY BOWEL DISEASE PATIENTS: PERSPECTIVE OF PHYSICIANS AND PATIENTS.

Iago Rodríguez-Lago  et al.

ADHERENCE TO VACCINATION RECOMMENDATIONS IN INFLAMMATORY BOWEL DISEASE PATIENT: A LONG WAY FOR IMPROVING.
ADHERENCE TO VACCINATION RECOMMENDATIONS IN INFLAMMATORY BOWEL DISEASE PATIENT: A LONG WAY FOR IMPROVING.

Iago Rodríguez-Lago  et al.

Item 1 - 20 / 41
1
2 3